Dr. Jason T. Huse, MD, PhD

Dr. Huse practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Huse's NPI, 1174771109, was assigned on September 3, 2008. Dr. Huse graduated from Perelman School of Medicine - Philadelphia in 2003. Dr. Huse holds Texas license Q9380.

Dr. Huse's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Huse's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Huse practices. Vendor and product names are available with a free account.

Neuropathology is Dr. Huse's primary specialty in the NPI Registry, under taxonomy code 207ZN0500X. Dr. Huse is board certified in neuropathology by the American Board of Pathology. Dmand AI has Dr. Huse's licenses on file in 3 states: Texas, New York and Pennsylvania.

CMS data shows 348 Medicare services from Dr. Huse across 7 procedure codes in 2024, for 116 Medicare patients. Medicare paid $12,785 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 116 Medicare patients who saw Dr. Huse in 2024. The largest group is 65 to 74, with 72 patients. 72% of them have high blood pressure, and 72% have high cholesterol. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Huse's median patient age at 53, with 30% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Huse for performance year 2024, reported as part of a group. Dr. Huse accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 171 papers to Dr. Huse, published from 2006 to 2025. 2019 was the busiest year, with 13. The most frequent topics are Brain Neoplasms, Glioma and Glioblastoma. Dr. Huse has published most often in Neuro Oncol. Dr. Huse's most frequent co-authors are Cameron W. Brennan, MD, Gregory N. Fuller, MD, PhD and Frederick F. Lang, MD.

CMS Open Payments shows 13 general payments to Dr. Huse from 3 drug and device companies from 2019 to 2024. Consulting fees make up the largest share, 79% of the total. Servier Pharmaceuticals LLC paid the most, $6,490.

Dr. Huse graduated from Perelman School of Medicine - Philadelphia in 2003.

Dr. Huse is in network with 4 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.